Addition of Rituximab to Either BEAC or BEAM in the Preparative Regimen Prior to Autologous Stem Cell Transplantation in Patients With Relapsed B-Cell Non-Hodgkin Lymphoma Does Not Add a Survival Benefit: A Single Center Experience
2011 ◽
Vol 17
(2)
◽
pp. S350
2014 ◽
Vol 20
(2)
◽
pp. S162-S163
2019 ◽
Vol 60
(14)
◽
pp. 3434-3441
◽
2009 ◽
Vol 15
(11)
◽
pp. 1447-1454
◽
2015 ◽
Vol 171
(2)
◽
pp. 197-204
◽